Please assess the completion status of the following clinical trial:

Trial Title: Indocyanine Green for Solid Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult patients over 18 years of age~2. Patients presenting with a solid tumor presumed to be resectable cancer and are at risk for local recurrence on pre-operative assessment~3. Good operative candidate as determined by the treating physician and multidisciplinary team~4. Subject capable of giving informed consent and participating in the process of consent.~Exclusion Criteria:~1. Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery~2. Subjects with a history of iodide allergies~3. Vulnerable patient populations~   1. People who would be easily lost to follow up~  2. Patients unable to participate in the consent process (children and neonates).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ICG injection group (Type: EXPERIMENTAL): This group will receive a single dose of ICG, infused over 40 minutes. During surgery, they will be imaged with a camera and an imaging probe the investigators have developed.

Based on this trial design, predict the completion outcome and termination type (if applicable).